RxDoctor Payments Data

Morgan Thomas

Physician Assistant · Burleson, TXNPI 1063936474

Payments from drug & device makers

$6,087in general payments, 2019–2025

Across 358 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$633
  • Takeda Pharmaceuticals U.S.A., Inc.$490
  • Lilly USA, LLC$488
  • Boehringer Ingelheim$482
  • Novo Nordisk$434
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$6,087100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,087 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$52,790
MounjaroTirzepatide24$28,489
ViberziEluxadoline11$15,937
Celecoxib31$1,724
Levothyroxine Sodium97$998
Omeprazole45$971
Gabapentin42$927
Montelukast Sodium37$611
Duloxetine Hcl16$525
Esomeprazole Magnesium15$466
Amlodipine Besylate57$456
ClopidogrelClopidogrel Bisulfate20$438
Losartan Potassium30$376
Lorazepam19$359
Lisinopril59$351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$434$52,79037 claims
Lilly USA, LLCMounjaro$488$28,48924 claims
AbbVieViberzi$1,349$15,93711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Burleson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →